查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美放射性药物治疗市场预测至 2028 年 - 区域分析 - 按产品类型、放射性同位素、来源、应用、适应症和最终用户
市场调查报告书
商品编码
1463668

北美放射性药物治疗市场预测至 2028 年 - 区域分析 - 按产品类型、放射性同位素、来源、应用、适应症和最终用户

North America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type, Radioisotope, Source, Application, Indication, and End User
出版日期: | 出版商: The Insight Partners | 英文 185 Pages | 订单完成后即时交付

价格

2022年北美放射性药物治疗诊断市值为7.9588亿美元，预计2028年将达到15.2995亿美元；预计2022年至2028年CAGR为11.5%。

在心血管疾病治疗的应用不断增加

心血管疾病（CVD）是21世纪最常见的慢性疾病之一，死亡率很高。由于久坐的生活方式，心血管疾病是已开发国家死亡和发病的主要原因。此外，肥胖和糖尿病以及相关疾病与心血管疾病有关，并且正在成为共病。此外，冠状动脉阻塞等併发症是成人死亡的首要原因之一，导致动脉壁内膜（主要是颈动脉）形成血栓斑块。心血管疾病的治疗应用包括奈米药物在心绞痛、心肌炎、心肌梗塞、心包膜疾病、血栓形成、动脉粥状硬化、高血脂、高血压、肺动脉高压和中风的应用。治疗诊断奈米药物可以延长体循环，逃避宿主防御系统，并将治疗诊断剂递送到目标部位，以在细胞和分子层面上进行成像和治疗。

根据美国疾病管制与预防中心 (CDC) 2022 年的报告，心臟病是美国男性和女性死亡的主要原因。 2020 年，心臟病导緻美国约697,000 人死亡，即五分之一的死亡。克服复杂性和病理生理学问题与 CVD 相关的併发症。动脉粥状硬化患者的心血管影像提供了有助于治疗心血管疾病的病理生理学证据。此外，治疗诊断奈米颗粒可以与一系列成像技术相结合，例如磁振造影、正子断层扫描（PET）和电脑断层扫描（CT）。迄今为止，已经在临床实验室进行了各种临床研究。透过将聚合物光声探针与奈米颗粒 PLCDP@PMH 结合，建构了三合一治疗复合物。临床体内评估表明，PLCDP@PMH 为患者早期动脉粥状硬化检测的治疗诊断方法提供了有利可图的优势。

北美放射性药物治疗市场概述

北美放射性药物治疗诊断市场分为美国、加拿大和墨西哥。预计美国将成为放射性药物治疗市场的最大贡献者之一。该地区的市场成长归因于慢性病发病率的增加、政府支持计划的存在、市场参与者不断增长的战略倡议以及创新放射疗法的发展。

北美放射性药物治疗市场收入及 2028 年预测（百万美元）

北美放射性药物治疗诊断市场细分

北美放射性药物治疗诊断市场分为产品类型、放射性同位素、来源、应用、适应症、最终用户和国家。根据产品类型，北美放射性药物治疗诊断市场分为 α 发射器、β 发射器和正子断层扫描 (PET) 示踪剂。 2022 年，PET 示踪剂领域占据最大的市场份额。

根据放射性同位素，北美放射性药物治疗市场分为锝-99、镓-68、碘-131、碘-123、氟-18 (18F)、钇 90 (Y-90)、铠 (Lu) 177、铜（ Cu）67、铜（Cu）64等。镥 (Lu) 177 细分市场在 2022 年占据最大的市场份额。

根据消息来源，北美放射性药物治疗诊断市场分为核反应器和迴旋加速器。到 2022 年，迴旋加速器领域将占据更大的市场份额。

根据应用，北美放射性药物治疗诊断市场分为标靶治疗 (Rx) 和伴随诊断 (CDx)。 2022 年，标靶治疗 (Rx) 领域占据了更大的市场份额。

根据适应症，北美放射性药物治疗诊断市场分为肿瘤学、心臟科、神经学等。 2022 年，肿瘤学领域占据最大的市场。

根据最终用户，北美放射性药物治疗诊断市场分为医院、诊断影像中心、学术和研究机构等。 2022 年，肿瘤学领域占据最大的市场。

按国家/地区划分，北美放射性药物治疗诊断市场分为美国、加拿大和墨西哥。 2022 年，美国在北美放射性药物治疗诊断市场份额中占据主导地位。

拜耳公司；通用电气医疗保健技术公司；锔; Lantheus 医学影像公司； Telix 製药有限公司；康德乐健康公司；高级加速器应用 SA；欢欣鼓舞的放射製药公司；治疗诊断学；和 NuView Life Sciences 是北美放射性药物治疗市场的领先公司。

目录

第 1 章：简介

第 2 章：放射性药物治疗市场 - 要点

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美放射性药物治疗诊断市场 - 市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
  • 专家意见

第 5 章：北美放射性药物治疗诊断市场 - 主要市场动态

  • 市场驱动因素
    • 癌症发生率上升
    • 在心血管疾病治疗的应用不断增加
  • 市场限制
    • 批准放射性药物治疗的监管挑战
  • 市场机会
    • 用于个人化放射性药物治疗的治疗诊断数位孪生
  • 未来的趋势
    • 核子医学中的放射性药物治疗诊断学
  • 影响分析

第 6 章：放射性药物治疗市场 - 北美分析

  • 北美放射性药物治疗市场收入预测与分析

第 7 章：北美放射性药物治疗市场 - 2028 年收入与预测 - 按产品类型

  • 概述
  • 2021 年和 2028 年按产品类型分類的放射性药物治疗市场收入份额 (%)

第 8 章：北美放射性药物治疗市场分析 - 按放射性同位素

  • 概述
  • 2021 年和 2028 年放射性药物治疗市场收入份额（按放射性同位素划分）（%）

第 9 章：北美放射性药物治疗市场分析 - 按来源

  • 概述
  • 2021 年及 2028 年放射性药物治疗市场收入份额（按来源划分）（%）

第 10 章：北美放射性药物治疗市场分析 - 按应用

  • 概述
  • 2021 年和 2028 年按应用分類的放射性药物治疗市场收入份额 (%)

第 11 章：北美放射性药物治疗市场分析 - 按适应症

  • 概述
  • 2021 年和 2028 年按适应症分類的放射性药物治疗市场收入份额 (%)

第 12 章：北美放射性药物治疗市场分析 - 按最终用户

  • 概述
  • 2021 年和 2028 年按最终用户分類的放射性药物治疗市场收入份额 (%)

第 13 章：北美放射性药物治疗市场 - 收入和 2028 年预测 - 按国家分析

  • 北美洲

第 14 章：放射性药物治疗市场 - 产业格局

  • 概述
  • 放射性药物治疗市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 15 章：公司简介

  • Bayer AG
  • GE HealthCare Technologies Inc
  • Curium
  • Lantheus Medical Imaging, Inc.
  • Telix Pharmaceuticals Ltd.
  • Cardinal Health Inc
  • Advanced Accelerator Applications S.A.
  • Jubilant Radiopharma
  • Theragnostics
  • NuView Life Sciences

第 16 章：附录

Product Code: BMIRE00028187

The North America radiopharmaceutical theranostics market was valued at US$ 795.88 million in 2022 and is expected to reach US$ 1,529.95 million by 2028; it is estimated to register a CAGR of 11.5% from 2022 to 2028.

Rising Application in Treatment of Cardiovascular Disorders

Cardiovascular diseases (CVDs) are among the most prevalent chronic diseases of the 21st century, with a high mortality rate. Due to their sedentary lifestyle, CVDs are the leading cause of mortality and morbidity in developed countries. In addition, obesity and diabetes, and related diseases are associated with cardiovascular disease and are becoming comorbid. In addition, a complication such as coronary artery obstruction is one of the number one causes of death in adults, resulting in thrombus plaque in the intima of the arterial wall, mainly in the carotid artery. Therapeutic applications in cardiovascular diseases include nanomedicine in angina pectoris, myocarditis, myocardial infarction, pericardial disease, thrombosis, atherosclerosis, hyperlipidemia, hypertension, pulmonary arterial hypertension, and stroke. Theranostic nanomedicines can prolong systemic circulation, evade host defense systems, and deliver theranostic agents to the target site for imaging and therapy at the cellular and molecular levels.

As per the 2022 report by the Centers for Disease Control and Prevention (CDC), heart disease is a leading cause of death among men and women in the US. Heart disease was a cause of ~697,000 deaths, i.e., 1 in 5 deaths, in the US in 2020. A National Institute of Health report states that theranostic nanoparticles have gained significant attention in the medical field, as the techniques help overcome complexities and pathophysiological complications associated with CVDs. Cardiovascular imaging of atherosclerosis patients provides pathophysiological evidence that can help treat CVDs. Further, theranostic nanoparticles can be combined with a range of imaging techniques, such as magnetic resonance imaging, positron emission tomography (PET), and computed tomography (CT). Various clinical research studies have been conducted in clinical laboratories so far. A three-in-one therapeutic complex has been constructed, by combining a polymeric photoacoustic probe with nanoparticles-PLCDP@PMH. Clinical in-vivo evaluations reveal that the PLCDP@PMH provides lucrative advantages for the theranostics approach to early-stage atherosclerosis detection in patients.

North America Radiopharmaceutical Theranostics Market Overview

The North America radiopharmaceutical theranostics market is segmented into US, Canada, and Mexico. The US is expected to be among the largest contributors to the radiopharmaceutical theranostics market. The market growth in this region is due to the increasing incidences of chronic diseases, presence of supportive government plans, growing strategic initiatives by the market players, and development of innovative radiotherapies.

North America Radiopharmaceutical Theranostics Market Revenue and Forecast to 2028 (US$ Million)

North America Radiopharmaceutical Theranostics Market Segmentation

The North America radiopharmaceutical theranostics market is segmented into product type, radioisotope, source, application, indication, end user, and country. Based on product type, the North America radiopharmaceutical theranostics market is segmented into alpha emitters, beta emitters, and Positron Emission Tomography (PET) tracers. The PET tracers segment held the largest market share in 2022.

Based on radioisotope, the North America radiopharmaceutical theranostics market is segmented into technetium-99, gallium-68, iodine-131, iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and others. The Lutetium (Lu) 177 segment held the largest market share in 2022.

Based on source, the North America radiopharmaceutical theranostics market is bifurcated into nuclear reactors and cyclotrons. The cyclotrons segment held a larger market share in 2022.

Based on application, the North America radiopharmaceutical theranostics market is bifurcated into targeted therapeutic (Rx) and Companion Diagnostic (CDx). The targeted therapeutic (Rx) segment held a larger market share in 2022.

Based on indication, the North America radiopharmaceutical theranostics market is segmented into oncology, cardiology, neurology, and others. The oncology segment held the largest market share in 2022.

Based on end user, the North America radiopharmaceutical theranostics market is segmented into hospitals, diagnostic imaging centers, academic and research institutes, and others. The oncology segment held the largest market share in 2022.

Based on country, the North America radiopharmaceutical theranostics market is segmented into the US, Canada, and Mexico. The US dominated the North America radiopharmaceutical theranostics market share in 2022.

Bayer AG; GE Healthcare Technologies Inc.; Curium; Lantheus Medical Imaging, Inc.; Telix Pharmaceuticals Ltd.; Cardinal Health Inc.; Advanced Accelerator Applications S.A; Jubilant Radiopharma; Theragnostics; and NuView Life Sciences are the leading companies operating in the North America radiopharmaceutical theranostics market.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 North America Radiopharmaceutical Theranostics Market - by Product Type
    • 1.3.2 North America Radiopharmaceutical Theranostics Market - by Radioisotope
    • 1.3.3 North America Radiopharmaceutical Theranostics Market - by Source
    • 1.3.4 North America Radiopharmaceutical Theranostics Market - by Application
    • 1.3.5 North America Radiopharmaceutical Theranostics Market - by Indication
    • 1.3.6 North America Radiopharmaceutical Theranostics Market - by End User
    • 1.3.7 North America Radiopharmaceutical Theranostics Market - by Country

2. Radiopharmaceutical Theranostics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Radiopharmaceutical Theranostics Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
  • 4.3 Expert's Opinion

5. North America Radiopharmaceutical Theranostics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Incidence of Cancer
    • 5.1.2 Rising Application in Treatment of Cardiovascular Disorders
  • 5.2 Market Restraints
    • 5.2.1 Regulatory Challenges for Approval of Radiopharmaceutical Theranostics
  • 5.3 Market Opportunities
    • 5.3.1 Theranostic Digital Twins for Personalized Radiopharmaceutical Therapies
  • 5.4 Future Trends
    • 5.4.1 Radiopharmaceutical Theranostics in Nuclear Medicine
  • 5.5 Impact Analysis

6. Radiopharmaceutical Theranostics Market - North America Analysis

  • 6.1 North America Radiopharmaceutical Theranostics Market Revenue Forecast and Analysis

7. North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Product Type

  • 7.1 Overview
  • 7.2 Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
    • 7.2.1 Positron Emission Tomography (PET) Tracers
      • 7.2.1.1 Overview
      • 7.2.1.2 Positron Emission Tomography (PET) Tracers: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.2.2 Beta Emitters
      • 7.2.2.1 Overview
      • 7.2.2.2 Beta Emitters: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.2.3 Alpha Emitters
      • 7.2.3.1 Overview
      • 7.2.3.2 Alpha Emitters: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Radiopharmaceutical Theranostics Market Analysis - by Radioisotope

  • 8.1 Overview
  • 8.2 Radiopharmaceutical Theranostics Market Revenue Share, by Radioisotope 2021 & 2028 (%)
    • 8.2.1 Technetium-99
      • 8.2.1.1 Overview
      • 8.2.1.2 Technetium-99: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.2 Gallium-68
      • 8.2.2.1 Overview
      • 8.2.2.2 Gallium-68: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.3 Iodine-131
      • 8.2.3.1 Overview
      • 8.2.3.2 Iodine-131: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.4 Iodine-123
      • 8.2.4.1 Overview
      • 8.2.4.2 Iodine-123: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.5 Fluorine-18 (18F)
      • 8.2.5.1 Overview
      • 8.2.5.2 Fluorine-18 (18F): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.6 Yttrium 90 (Y-90)
      • 8.2.6.1 Overview
      • 8.2.6.2 Yttrium 90 (Y-90): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.7 Lutetium (LU) 177
      • 8.2.7.1 Overview
      • 8.2.7.2 Lutetium (LU) 177: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.8 Copper (CU) 67
      • 8.2.8.1 Overview
      • 8.2.8.2 Copper (CU) 67: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.9 Copper (CU) 64
      • 8.2.9.1 Overview
      • 8.2.9.2 Copper (CU) 64: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.2.10 Others
      • 8.2.10.1 Overview
      • 8.2.10.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Radiopharmaceutical Theranostics Market Analysis - by Source

  • 9.1 Overview
  • 9.2 Radiopharmaceutical Theranostics Market Revenue Share, by Source 2021 & 2028 (%)
    • 9.2.1 Nuclear Reactors
      • 9.2.1.1 Overview
      • 9.2.1.2 Nuclear Reactors: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.2.2 Cyclotrons
      • 9.2.2.1 Overview
      • 9.2.2.2 Cyclotrons: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Radiopharmaceutical Theranostics Market Analysis - by Application

  • 10.1 Overview
  • 10.2 Radiopharmaceutical Theranostics Market Revenue Share, by Application 2021 & 2028 (%)
    • 10.2.1 Targeted Therapeutic (Rx)
      • 10.2.1.1 Overview
      • 10.2.1.2 Targeted Therapeutics (Rx): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.2 Companion Diagnostic (CDx)
      • 10.2.2.1 Overview
      • 10.2.2.2 Companion Diagnostics (CDx): Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

11. North America Radiopharmaceutical Theranostics Market Analysis - by Indication

  • 11.1 Overview
  • 11.2 Radiopharmaceutical Theranostics Market Revenue Share, by Indication 2021 & 2028 (%)
    • 11.2.1 Oncology
      • 11.2.1.1 Overview
      • 11.2.1.2 Oncology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.2 Neurology
      • 11.2.2.1 Overview
      • 11.2.2.2 Neurology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.3 Cardiology
      • 11.2.3.1 Overview
      • 11.2.3.2 Cardiology: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.4 Others
      • 11.2.4.1 Overview
      • 11.2.4.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

12. North America Radiopharmaceutical Theranostics Market Analysis - by End User

  • 12.1 Overview
  • 12.2 Radiopharmaceutical Theranostics Market Revenue Share, by End User 2021 & 2028 (%)
    • 12.2.1 Hospitals
      • 12.2.1.1 Overview
      • 12.2.1.2 Hospitals: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.2 Diagnostic Imaging Centers
      • 12.2.2.1 Overview
      • 12.2.2.2 Diagnostic Imaging Centers: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.3 Academic & Research Institutes
      • 12.2.3.1 Overview
      • 12.2.3.2 Academic & Research Institutes: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
    • 12.2.4 Others
      • 12.2.4.1 Overview
      • 12.2.4.2 Others: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)

13. North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 - by Country Analysis

  • 13.1 North America: Radiopharmaceutical Theranostics Market
    • 13.1.1 Overview
      • 13.1.1.1 United States: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.1.1.1 Overview
        • 13.1.1.1.2 United States: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.1.1.3 United States Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
        • 13.1.1.1.4 United States Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.1.1.5 United States Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.1.1.6 United States Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.1.1.7 United States Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.1.1.8 United States Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
      • 13.1.1.2 Canada: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.1.2.1 Overview
        • 13.1.1.2.2 Canada: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.1.2.3 Canada Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
        • 13.1.1.2.4 Canada Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.1.2.5 Canada Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.1.2.6 Canada Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.1.2.7 Canada Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.1.2.8 Canada Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)
      • 13.1.1.3 Mexico: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.1.3.1 Overview
        • 13.1.1.3.2 Mexico: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
        • 13.1.1.3.3 Mexico Radiopharmaceutical Theranostics Market, by Product Type, 2019-2028 (US$ Million)
        • 13.1.1.3.4 Mexico Radiopharmaceutical Theranostics Market, by Radioisotope, 2019-2028 (US$ Million)
        • 13.1.1.3.5 Mexico Radiopharmaceutical Theranostics Market, by Source, 2019-2028 (US$ Million)
        • 13.1.1.3.6 Mexico Radiopharmaceutical Theranostics Market, by Application, 2019-2028 (US$ Million)
        • 13.1.1.3.7 Mexico Radiopharmaceutical Theranostics Market, by Indication, 2019-2028 (US$ Million)
        • 13.1.1.3.8 Mexico Radiopharmaceutical Theranostics Market, by End User, 2019-2028 (US$ Million)

14. Radiopharmaceutical Theranostics Market - Industry Landscape

  • 14.1 Overview
  • 14.2 Growth Strategies in the Radiopharmaceutical Theranostics Market
  • 14.3 Inorganic Growth Strategies
    • 14.3.1 Overview
  • 14.4 Organic Growth Strategies
    • 14.4.1 Overview

15. Company Profiles

  • 15.1 Bayer AG
    • 15.1.1 Key Facts
    • 15.1.2 Business Description
    • 15.1.3 Products and Services
    • 15.1.4 Financial Overview
    • 15.1.5 SWOT Analysis
    • 15.1.6 Key Developments
  • 15.2 GE HealthCare Technologies Inc
    • 15.2.1 Key Facts
    • 15.2.2 Business Description
    • 15.2.3 Products and Services
    • 15.2.4 Financial Overview
    • 15.2.5 SWOT Analysis
    • 15.2.6 Key Developments
  • 15.3 Curium
    • 15.3.1 Key Facts
    • 15.3.2 Business Description
    • 15.3.3 Products and Services
    • 15.3.4 Financial Overview
    • 15.3.5 SWOT Analysis
    • 15.3.6 Key Developments
  • 15.4 Lantheus Medical Imaging, Inc.
    • 15.4.1 Key Facts
    • 15.4.2 Business Description
    • 15.4.3 Products and Services
    • 15.4.4 Financial Overview
    • 15.4.5 SWOT Analysis
    • 15.4.6 Key Developments
  • 15.5 Telix Pharmaceuticals Ltd.
    • 15.5.1 Key Facts
    • 15.5.2 Business Description
    • 15.5.3 Products and Services
    • 15.5.4 Financial Overview
    • 15.5.5 SWOT Analysis
    • 15.5.6 Key Developments
  • 15.6 Cardinal Health Inc
    • 15.6.1 Key Facts
    • 15.6.2 Business Description
    • 15.6.3 Products and Services
    • 15.6.4 Financial Overview
    • 15.6.5 SWOT Analysis
    • 15.6.6 Key Developments
  • 15.7 Advanced Accelerator Applications S.A.
    • 15.7.1 Key Facts
    • 15.7.2 Business Description
    • 15.7.3 Products and Services
    • 15.7.4 Financial Overview
    • 15.7.5 SWOT Analysis
    • 15.7.6 Key Developments
  • 15.8 Jubilant Radiopharma
    • 15.8.1 Key Facts
    • 15.8.2 Business Description
    • 15.8.3 Products and Services
    • 15.8.4 Financial Overview
    • 15.8.5 SWOT Analysis
    • 15.8.6 Key Developments
  • 15.9 Theragnostics
    • 15.9.1 Key Facts
    • 15.9.2 Business Description
    • 15.9.3 Products and Services
    • 15.9.4 Financial Overview
    • 15.9.5 SWOT Analysis
    • 15.9.6 Key Developments
  • 15.10 NuView Life Sciences
    • 15.10.1 Key Facts
    • 15.10.2 Business Description
    • 15.10.3 Products and Services
    • 15.10.4 Financial Overview
    • 15.10.5 SWOT Analysis
    • 15.10.6 Key Developments

16. Appendix

  • 16.1 About The Insight Partners
  • 16.2 Glossary of Terms

List Of Tables

  • Table 1. United States Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. United States Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. United States Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. United States Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. United States Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. United States Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Canada Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Canada Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico Radiopharmaceutical Theranostics Market, by Product Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Mexico Radiopharmaceutical Theranostics Market, by Radioisotope - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Mexico Radiopharmaceutical Theranostics Market, by Source - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Mexico Radiopharmaceutical Theranostics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Mexico Radiopharmaceutical Theranostics Market, by Indication - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Mexico Radiopharmaceutical Theranostics Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Recent Inorganic Growth Strategies in the Radiopharmaceutical Theranostics Market
  • Table 20. Recent Organic Growth Strategies in the Radiopharmaceutical Theranostics Market
  • Table 21. Glossary of Terms

List Of Figures

  • Figure 1. North America Radiopharmaceutical Theranostics Market Segmentation
  • Figure 2. North America Radiopharmaceutical Theranostics Market, by Country
  • Figure 3. North America Radiopharmaceutical Theranostics Market Overview
  • Figure 4. Positron Emission Tomography (PET) Tracers Segment Held Largest Share of Product Type Segment in Radiopharmaceutical Theranostics Market
  • Figure 5. US Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. North America: PEST Analysis
  • Figure 7. North America Experts' Opinion
  • Figure 8. North America Radiopharmaceutical Theranostics Market: Impact Analysis of Drivers and Restraints
  • Figure 9. North America Radiopharmaceutical Theranostics Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 10. North America Radiopharmaceutical Theranostics Market Revenue Share, by Product Type 2021 & 2028 (%)
  • Figure 11. Positron Emission Tomography (PET) Tracers: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Beta Emitters: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Alpha Emitters: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. North America Radiopharmaceutical Theranostics Market, by Radioisotope, 2021 & 2028 (%)
  • Figure 15. Technetium-99: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Gallium-68: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Iodine-131: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Iodine-123: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 19. Fluorine-18 (18F): North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Yttrium 90 (Y-90): North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Lutetium (LU) 177: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Copper (CU) 67: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Copper (CU) 64: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Others: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. North America Radiopharmaceutical Theranostics Market, by Source, 2021 & 2028 (%)
  • Figure 26. Nuclear Reactors: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Cyclotrons: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. North America Radiopharmaceutical Theranostics Market, by Application, 2021 & 2028 (%)
  • Figure 29. Targeted Therapeutics (Rx): North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Companion Diagnostics (CDx): North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. North America Radiopharmaceutical Theranostics Market, by Indication, 2021 & 2028 (%)
  • Figure 32. Oncology: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Neurology: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Cardiology: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Others: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. North America Radiopharmaceutical Theranostics Market, by End User, 2021 & 2028 (%)
  • Figure 37. Hospitals: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Diagnostic Imaging Centers: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Academic & Research Institutes: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. Others: North America Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. North America: Radiopharmaceutical Theranostics Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 42. North America: Radiopharmaceutical Theranostics Market, by Country, 2021 & 2028 (%)
  • Figure 43. United States: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Canada: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Mexico: Radiopharmaceutical Theranostics Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Growth Strategies in the Radiopharmaceutical Theranostics Market